share_log

Mind Cure Health Is Shutting Down All Operations, Citing Lack Of Funds To Move Forward

Mind Cure Health Is Shutting Down All Operations, Citing Lack Of Funds To Move Forward

Mind Cure Health以缺乏资金为由关闭所有业务
Benzinga Real-time News ·  2022/03/16 20:50

Mind Cure Health Inc. (CSE:MCUR) (OTCQX:MCURF) (FRA: 6MH), a mental health and wellness company working in the psychedelics sector, announced that a special committee its board of directors concluded a review process and has determined that the capital required to continue the Company's business plan is unlikely to be found under the current and foreseeable market conditions. 

Mind Cure Health Inc。(CSE:MCUR)(OTCQX:MCURF)(FRA:6MH)是一家从事迷幻药物领域的精神健康和健康公司,该公司宣布,其董事会成立了一个特别委员会,审查过程中,并已确定,在当前和可预见的市场条件下,不太可能找到继续本公司业务计划所需的资本。

Shutting Down

正在关闭

As such, the Board decided to immediately eliminate all expenditures outside those required to preserve the value of the Company's assets and will immediately cut all of its C-suite executives and employees, except for its CFO, vice president of engineering and certain administrative staff required to wind-down the its operations.

因此,董事会决定 立即取消公司资产保值所需支出以外的所有支出该公司将立即裁减所有高管和员工,但首席财务官、工程副总裁和某些需要逐步结束业务的行政人员除外。

"Though we continue the Strategic Review Process, we have identified no available strategic alternatives that would require further development and execution of MINDCURE's existing business plan," said the chair of MINDCURE's Special Committee, Jason Pamer

MINDCURE特别委员会主席表示:“尽管我们继续进行战略审查进程,但我们没有发现需要进一步制定和执行MINDCURE现有业务计划的可用战略选择。”杰森·帕默.

The Company will also stop all non-committed expenditures related to the development and marketing work of its iSTRYM product, R&D related to its synthetic ibogaine program and R&D related to its Desire Project.

公司也将停止所有与其iSTRYM产品的开发和营销工作有关的未承诺支出,与其合成ibogaine计划有关的研发,以及与其Desire Project有关的研发。

"While we truly appreciate the impact of these changes on our team and our suppliers, our Strategic Review Process has led us to believe that the actions announced in this news release are necessary to preserve cash position and maintain value of the Company's other assets while the Company continues to seek a strategic transaction," said Philip Tapley, chair of MINDCURE's board of directors and interim CEO.

虽然我们真正理解这些变化对我们的团队和我们的供应商的影响,但我们的战略审查过程使我们相信,在公司继续寻求战略交易的同时,本新闻稿中宣布的行动对于保持公司的现金状况和其他资产的价值是必要的。菲利普·塔普利MINDCURE董事会主席兼临时首席执行官。

Other than what was described in a company press release, Mind Cure has not announced any decisions related to strategic alternatives or expressed assurances regarding the evaluation of strategic alternatives.

与公司新闻稿中所描述的不同,Mind Cure尚未宣布任何与战略选择有关的决定,也没有就战略选择的评估表示保证。

"The Company does not intend to comment further unless and until further disclosure is appropriate or necessary," according the release.

根据新闻稿,公司不打算进一步置评,除非进一步披露是适当的或有必要的。

Mind Cure's stock stopped trading when the news was announced but did resume after a few hours and then fell by 38%.

消息公布后,Mind Cure的股票停止交易,但几个小时后确实恢复了交易,随后下跌了38%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发